Inventor · disambiguated record
Hyejin Chung
Also filed as: CHUNG HYEJIN
10 granted patents·6 pending applications·38 citations·filing 2008–2025
85Inventor score
Top patents by PatentIndex Score
16 records- 0187US7785875B2Polynucleotide encoding HCV epitopes which can bind to various HLA supertypes, immunogenic composition comprising same and method of inducing an HCV-specific immune response using sameMOGAM BIOTECH RES INST·Filed 2008·Granted Aug 31, 2010·11 cites·15 claims
- 0286US11891445B1Anti-B7-H3 antibody and use thereofABL BIO INC·Filed 2019·Granted Feb 6, 2024·5 cites·14 claims
- 0382US9834753B2Method for producing natural killer cells, natural killer cells produced thereby, and composition for treating cancers and infectious diseases containing the sameMOGAM BIOTECHNOLOGY INST·Filed 2012·Granted Dec 5, 2017·16 cites·9 claims
- 0478US12240913B2Anti-HER2/anti-4-1BB bispecific antibody and use thereofABL BIO INC·Filed 2020·Granted Mar 4, 2025·1 cites·6 claims
- 0577US12195538B2Anti-PD-L1/anti-4-1BB bispecific antibodies and uses thereofABL BIO INC·Filed 2019·Granted Jan 14, 2025·1 cites·10 claims
- 0675US12252541B2Anti-BCMA antibody and use thereofABL BIO INC·Filed 2019·Granted Mar 18, 2025·2 cites·9 claims
- 0775US12195537B2Anti-4-1BB antibody and use thereofABL BIO INC·Filed 2019·Granted Jan 14, 2025·1 cites·4 claims
- 0873US12071483B1Bispecific antibody to alpha-synuclein/insulin-like growth factor 1 receptor and use thereofABL BIO INC·Filed 2018·Granted Aug 27, 2024·1 cites·18 claims
- 0971US2025066487A1Anti-egfr/anti-4-1bb bispecific antibody and use thereofABL BIO INC·Filed 2024·Application pending·0 cites
- 1068US2024101687A1Bispecific Antibody to A-Syn/IGF1R and Use ThereofABL BIO INC·Filed 2023·Application pending·0 cites
- 1164US2025145718A1Anti-pd-l1/anti-4-1bb bispecific antibodies and uses thereofABL BIO INC·Filed 2025·Application pending·0 cites
- 1262US2025215112A1Pharmaceutical composition for treating or preventing cancer with low expression level of her2YUHAN CORP·Filed 2023·Application pending·0 cites
- 1355US12168690B2Anti-EGFR/anti-4-1BB bispecific antibodyABL BIO INC·Filed 2020·Granted Dec 17, 2024·0 cites·6 claims
- 1454US2025163180A1Anti-her2/anti-4-1bb bispecific antibody and use thereofABL BIO INC·Filed 2025·Application pending·0 cites
- 1550US2024383983A1Anti-B7-H4/Anti-4-1BB Bispecific Antibodies And Use ThereofABL BIO INC·Filed 2021·Application pending·0 cites
- 1647US12122830B1Anti-ROR1 antibody and use thereofABL BIO INC·Filed 2019·Granted Oct 22, 2024·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Hyejin Chung files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →